nodes	percent_of_prediction	percent_of_DWPC	metapath
Venlafaxine—CYP2C9—brain cancer	0.502	1	CbGaD
Venlafaxine—CYP2D6—Lomustine—brain cancer	0.0557	0.196	CbGbCtD
Venlafaxine—ABCG2—Carboplatin—brain cancer	0.0472	0.166	CbGbCtD
Venlafaxine—CYP2D6—Hydroxyurea—brain cancer	0.0422	0.148	CbGbCtD
Venlafaxine—CYP3A4—Temozolomide—brain cancer	0.0417	0.146	CbGbCtD
Venlafaxine—ABCG2—Etoposide—brain cancer	0.0396	0.139	CbGbCtD
Venlafaxine—CYP3A4—Lomustine—brain cancer	0.0354	0.124	CbGbCtD
Venlafaxine—ABCB1—Etoposide—brain cancer	0.0143	0.0502	CbGbCtD
Venlafaxine—CYP3A4—Etoposide—brain cancer	0.00856	0.0301	CbGbCtD
Venlafaxine—SLC6A3—telencephalic ventricle—brain cancer	0.00284	0.0754	CbGeAlD
Venlafaxine—SLC6A3—ganglion—brain cancer	0.00177	0.0469	CbGeAlD
Venlafaxine—NPY1R—telencephalon—brain cancer	0.00162	0.043	CbGeAlD
Venlafaxine—SLC6A4—ganglion—brain cancer	0.00162	0.043	CbGeAlD
Venlafaxine—SLC6A2—ganglion—brain cancer	0.00143	0.0379	CbGeAlD
Venlafaxine—NPY1R—gonad—brain cancer	0.00135	0.0359	CbGeAlD
Venlafaxine—SLC6A3—hindbrain—brain cancer	0.00134	0.0356	CbGeAlD
Venlafaxine—NPY1R—pituitary gland—brain cancer	0.00132	0.035	CbGeAlD
Venlafaxine—SLC6A3—Dopaminergic Neurogenesis—OTX2—brain cancer	0.00131	0.0526	CbGpPWpGaD
Venlafaxine—SLC6A4—hindbrain—brain cancer	0.00123	0.0326	CbGeAlD
Venlafaxine—NPY1R—endocrine gland—brain cancer	0.00102	0.0271	CbGeAlD
Venlafaxine—NPY1R—head—brain cancer	0.00101	0.0268	CbGeAlD
Venlafaxine—CYP2B6—CYP2E1 reactions—CYP2C9—brain cancer	0.00101	0.0405	CbGpPWpGaD
Venlafaxine—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000982	0.0395	CbGpPWpGaD
Venlafaxine—NPY1R—central nervous system—brain cancer	0.000922	0.0245	CbGeAlD
Venlafaxine—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000893	0.0359	CbGpPWpGaD
Venlafaxine—SLC6A4—Synaptic Vesicle Pathway—SYP—brain cancer	0.000851	0.0342	CbGpPWpGaD
Venlafaxine—SLC6A3—brainstem—brain cancer	0.000769	0.0204	CbGeAlD
Venlafaxine—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.000761	0.0306	CbGpPWpGaD
Venlafaxine—NPY1R—brain—brain cancer	0.000732	0.0194	CbGeAlD
Venlafaxine—SLC6A4—brainstem—brain cancer	0.000705	0.0187	CbGeAlD
Venlafaxine—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.0007	0.0281	CbGpPWpGaD
Venlafaxine—SLC6A3—telencephalon—brain cancer	0.000683	0.0181	CbGeAlD
Venlafaxine—SLC6A4—telencephalon—brain cancer	0.000626	0.0166	CbGeAlD
Venlafaxine—CYP2B6—Xenobiotics—CYP2C9—brain cancer	0.000624	0.0251	CbGpPWpGaD
Venlafaxine—SLC6A2—brainstem—brain cancer	0.000621	0.0165	CbGeAlD
Venlafaxine—CYP2D6—hindbrain—brain cancer	0.000593	0.0157	CbGeAlD
Venlafaxine—SLC6A3—Dopaminergic Neurogenesis—GLI2—brain cancer	0.000569	0.0229	CbGpPWpGaD
Venlafaxine—SLC6A2—telencephalon—brain cancer	0.000551	0.0146	CbGeAlD
Venlafaxine—SLC6A3—Dopaminergic Neurogenesis—GLI1—brain cancer	0.000535	0.0215	CbGpPWpGaD
Venlafaxine—SLC6A3—midbrain—brain cancer	0.00049	0.013	CbGeAlD
Venlafaxine—SLC6A3—spinal cord—brain cancer	0.000478	0.0127	CbGeAlD
Venlafaxine—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000472	0.019	CbGpPWpGaD
Venlafaxine—SLC6A2—gonad—brain cancer	0.00046	0.0122	CbGeAlD
Venlafaxine—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000454	0.0182	CbGpPWpGaD
Venlafaxine—SLC6A4—midbrain—brain cancer	0.000449	0.0119	CbGeAlD
Venlafaxine—ABCB1—blood vessel—brain cancer	0.000447	0.0119	CbGeAlD
Venlafaxine—ABCG2—telencephalon—brain cancer	0.00044	0.0117	CbGeAlD
Venlafaxine—SLC6A4—spinal cord—brain cancer	0.000438	0.0116	CbGeAlD
Venlafaxine—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000434	0.0174	CbGpPWpGaD
Venlafaxine—SLC6A2—medulla oblongata—brain cancer	0.000433	0.0115	CbGeAlD
Venlafaxine—CYP2B6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000428	0.0172	CbGpPWpGaD
Venlafaxine—SLC6A3—head—brain cancer	0.000425	0.0113	CbGeAlD
Venlafaxine—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000417	0.0168	CbGpPWpGaD
Venlafaxine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000408	0.0164	CbGpPWpGaD
Venlafaxine—SLC6A4—endocrine gland—brain cancer	0.000395	0.0105	CbGeAlD
Venlafaxine—SLC6A4—head—brain cancer	0.00039	0.0103	CbGeAlD
Venlafaxine—SLC6A3—central nervous system—brain cancer	0.000388	0.0103	CbGeAlD
Venlafaxine—SLC6A3—Dopaminergic Neurogenesis—SHH—brain cancer	0.000387	0.0156	CbGpPWpGaD
Venlafaxine—SLC6A3—cerebellum—brain cancer	0.000379	0.0101	CbGeAlD
Venlafaxine—ABCG2—pituitary gland—brain cancer	0.000358	0.0095	CbGeAlD
Venlafaxine—SLC6A4—central nervous system—brain cancer	0.000356	0.00943	CbGeAlD
Venlafaxine—SLC6A2—endocrine gland—brain cancer	0.000347	0.00921	CbGeAlD
Venlafaxine—ABCG2—medulla oblongata—brain cancer	0.000346	0.00916	CbGeAlD
Venlafaxine—SLC6A2—head—brain cancer	0.000343	0.00909	CbGeAlD
Venlafaxine—CYP2D6—brainstem—brain cancer	0.00034	0.00901	CbGeAlD
Venlafaxine—CYP2B6—gonad—brain cancer	0.000339	0.00898	CbGeAlD
Venlafaxine—CYP2C19—endocrine gland—brain cancer	0.000327	0.00867	CbGeAlD
Venlafaxine—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000324	0.013	CbGpPWpGaD
Venlafaxine—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000316	0.0127	CbGpPWpGaD
Venlafaxine—ABCG2—midbrain—brain cancer	0.000316	0.00838	CbGeAlD
Venlafaxine—SLC6A2—central nervous system—brain cancer	0.000313	0.0083	CbGeAlD
Venlafaxine—ABCG2—spinal cord—brain cancer	0.000308	0.00817	CbGeAlD
Venlafaxine—SLC6A3—brain—brain cancer	0.000308	0.00817	CbGeAlD
Venlafaxine—CYP2D6—telencephalon—brain cancer	0.000302	0.008	CbGeAlD
Venlafaxine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000301	0.0121	CbGpPWpGaD
Venlafaxine—ABCG2—Irinotecan Pathway—APC—brain cancer	0.0003	0.0121	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—PTCH2—brain cancer	0.000294	0.0118	CbGpPWpGaD
Venlafaxine—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000284	0.0114	CbGpPWpGaD
Venlafaxine—SLC6A4—brain—brain cancer	0.000282	0.00748	CbGeAlD
Venlafaxine—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000273	0.011	CbGpPWpGaD
Venlafaxine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000259	0.0104	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—OR14C36—brain cancer	0.000257	0.0103	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—OR4C12—brain cancer	0.000257	0.0103	CbGpPWpGaD
Venlafaxine—CYP2B6—endocrine gland—brain cancer	0.000256	0.00679	CbGeAlD
Venlafaxine—CYP2B6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000256	0.0103	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—HES5—brain cancer	0.000255	0.0103	CbGpPWpGaD
Venlafaxine—CYP2C9—endocrine gland—brain cancer	0.000253	0.00672	CbGeAlD
Venlafaxine—CYP2B6—head—brain cancer	0.000253	0.0067	CbGeAlD
Venlafaxine—SLC6A2—brain—brain cancer	0.000249	0.00659	CbGeAlD
Venlafaxine—ABCG2—cerebellum—brain cancer	0.000244	0.00648	CbGeAlD
Venlafaxine—NPY1R—Signaling by GPCR—OR14C36—brain cancer	0.000234	0.0094	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—OR4C12—brain cancer	0.000234	0.0094	CbGpPWpGaD
Venlafaxine—CYP2B6—central nervous system—brain cancer	0.000231	0.00612	CbGeAlD
Venlafaxine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000228	0.00916	CbGpPWpGaD
Venlafaxine—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000227	0.00911	CbGpPWpGaD
Venlafaxine—ABCB1—telencephalon—brain cancer	0.000217	0.00575	CbGeAlD
Venlafaxine—SLC6A4—Circadian rythm related genes—NTRK3—brain cancer	0.000215	0.00865	CbGpPWpGaD
Venlafaxine—CYP2B6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00021	0.00845	CbGpPWpGaD
Venlafaxine—ABCG2—HIF-2-alpha transcription factor network—SIRT1—brain cancer	0.000207	0.00834	CbGpPWpGaD
Venlafaxine—SLC6A3—Parkinsons Disease Pathway—CCNE1—brain cancer	0.000204	0.00819	CbGpPWpGaD
Venlafaxine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000203	0.00816	CbGpPWpGaD
Venlafaxine—Photosensitivity reaction—Temozolomide—brain cancer	0.000203	0.00134	CcSEcCtD
Venlafaxine—Weight increased—Temozolomide—brain cancer	0.000202	0.00134	CcSEcCtD
Venlafaxine—Hyperhidrosis—Procarbazine—brain cancer	0.000202	0.00134	CcSEcCtD
Venlafaxine—Renal failure—Carmustine—brain cancer	0.000202	0.00134	CcSEcCtD
Venlafaxine—Alopecia—Hydroxyurea—brain cancer	0.000201	0.00133	CcSEcCtD
Venlafaxine—Weight decreased—Temozolomide—brain cancer	0.000201	0.00133	CcSEcCtD
Venlafaxine—Neuropathy peripheral—Carmustine—brain cancer	0.000201	0.00133	CcSEcCtD
Venlafaxine—Hyperglycaemia—Temozolomide—brain cancer	0.000201	0.00133	CcSEcCtD
Venlafaxine—Stomatitis—Carmustine—brain cancer	0.0002	0.00132	CcSEcCtD
Venlafaxine—Pneumonia—Temozolomide—brain cancer	0.000199	0.00132	CcSEcCtD
Venlafaxine—Anorexia—Procarbazine—brain cancer	0.000199	0.00132	CcSEcCtD
Venlafaxine—ABCG2—brain—brain cancer	0.000198	0.00526	CbGeAlD
Venlafaxine—Erythema—Hydroxyurea—brain cancer	0.000198	0.00131	CcSEcCtD
Venlafaxine—Depression—Temozolomide—brain cancer	0.000198	0.00131	CcSEcCtD
Venlafaxine—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000197	0.0013	CcSEcCtD
Venlafaxine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000196	0.00787	CbGpPWpGaD
Venlafaxine—Cardiac arrest—Etoposide—brain cancer	0.000196	0.0013	CcSEcCtD
Venlafaxine—Nausea—Lomustine—brain cancer	0.000196	0.0013	CcSEcCtD
Venlafaxine—Hypotension—Procarbazine—brain cancer	0.000195	0.00129	CcSEcCtD
Venlafaxine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000195	0.00783	CbGpPWpGaD
Venlafaxine—Neuropathy peripheral—Temozolomide—brain cancer	0.000194	0.00129	CcSEcCtD
Venlafaxine—CYP3A4—endocrine gland—brain cancer	0.000193	0.00512	CbGeAlD
Venlafaxine—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000193	0.00777	CbGpPWpGaD
Venlafaxine—Stomatitis—Temozolomide—brain cancer	0.000193	0.00128	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000191	0.00126	CcSEcCtD
Venlafaxine—CYP2D6—endocrine gland—brain cancer	0.00019	0.00504	CbGeAlD
Venlafaxine—Insomnia—Procarbazine—brain cancer	0.000189	0.00125	CcSEcCtD
Venlafaxine—CYP2D6—head—brain cancer	0.000188	0.00498	CbGeAlD
Venlafaxine—Paraesthesia—Procarbazine—brain cancer	0.000188	0.00124	CcSEcCtD
Venlafaxine—Sinusitis—Temozolomide—brain cancer	0.000186	0.00123	CcSEcCtD
Venlafaxine—Somnolence—Procarbazine—brain cancer	0.000186	0.00123	CcSEcCtD
Venlafaxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000185	0.00746	CbGpPWpGaD
Venlafaxine—Cramp muscle—Etoposide—brain cancer	0.000185	0.00123	CcSEcCtD
Venlafaxine—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000185	0.00123	CcSEcCtD
Venlafaxine—Haemoglobin—Carmustine—brain cancer	0.000185	0.00123	CcSEcCtD
Venlafaxine—Haemorrhage—Carmustine—brain cancer	0.000184	0.00122	CcSEcCtD
Venlafaxine—Ill-defined disorder—Hydroxyurea—brain cancer	0.000184	0.00122	CcSEcCtD
Venlafaxine—Anaemia—Hydroxyurea—brain cancer	0.000183	0.00121	CcSEcCtD
Venlafaxine—Hypoaesthesia—Carmustine—brain cancer	0.000183	0.00121	CcSEcCtD
Venlafaxine—Hallucination—Carmustine—brain cancer	0.000183	0.00121	CcSEcCtD
Venlafaxine—CYP2B6—brain—brain cancer	0.000183	0.00486	CbGeAlD
Venlafaxine—Decreased appetite—Procarbazine—brain cancer	0.000182	0.0012	CcSEcCtD
Venlafaxine—Alanine aminotransferase increased—Etoposide—brain cancer	0.000182	0.0012	CcSEcCtD
Venlafaxine—ABCB1—gonad—brain cancer	0.000181	0.0048	CbGeAlD
Venlafaxine—Fatigue—Procarbazine—brain cancer	0.00018	0.00119	CcSEcCtD
Venlafaxine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00018	0.00724	CbGpPWpGaD
Venlafaxine—Haemoglobin—Temozolomide—brain cancer	0.000179	0.00119	CcSEcCtD
Venlafaxine—Malaise—Hydroxyurea—brain cancer	0.000179	0.00118	CcSEcCtD
Venlafaxine—Constipation—Procarbazine—brain cancer	0.000179	0.00118	CcSEcCtD
Venlafaxine—Pain—Procarbazine—brain cancer	0.000179	0.00118	CcSEcCtD
Venlafaxine—Haemorrhage—Temozolomide—brain cancer	0.000178	0.00118	CcSEcCtD
Venlafaxine—Hepatitis—Temozolomide—brain cancer	0.000178	0.00118	CcSEcCtD
Venlafaxine—Dysphagia—Etoposide—brain cancer	0.000178	0.00118	CcSEcCtD
Venlafaxine—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000178	0.00715	CbGpPWpGaD
Venlafaxine—Leukopenia—Hydroxyurea—brain cancer	0.000177	0.00118	CcSEcCtD
Venlafaxine—Visual impairment—Carmustine—brain cancer	0.000177	0.00118	CcSEcCtD
Venlafaxine—Hallucination—Temozolomide—brain cancer	0.000177	0.00117	CcSEcCtD
Venlafaxine—Hypoaesthesia—Temozolomide—brain cancer	0.000177	0.00117	CcSEcCtD
Venlafaxine—ABCB1—pituitary gland—brain cancer	0.000177	0.00468	CbGeAlD
Venlafaxine—Pharyngitis—Temozolomide—brain cancer	0.000177	0.00117	CcSEcCtD
Venlafaxine—CYP3A4—central nervous system—brain cancer	0.000174	0.00462	CbGeAlD
Venlafaxine—Feeling abnormal—Procarbazine—brain cancer	0.000172	0.00114	CcSEcCtD
Venlafaxine—Convulsion—Hydroxyurea—brain cancer	0.000172	0.00114	CcSEcCtD
Venlafaxine—Visual impairment—Temozolomide—brain cancer	0.000171	0.00114	CcSEcCtD
Venlafaxine—CYP2D6—central nervous system—brain cancer	0.000171	0.00454	CbGeAlD
Venlafaxine—Gastrointestinal pain—Procarbazine—brain cancer	0.000171	0.00113	CcSEcCtD
Venlafaxine—Flushing—Carmustine—brain cancer	0.000171	0.00113	CcSEcCtD
Venlafaxine—ABCB1—medulla oblongata—brain cancer	0.00017	0.00452	CbGeAlD
Venlafaxine—Pancytopenia—Etoposide—brain cancer	0.000169	0.00112	CcSEcCtD
Venlafaxine—Erythema multiforme—Temozolomide—brain cancer	0.000168	0.00111	CcSEcCtD
Venlafaxine—CYP2D6—cerebellum—brain cancer	0.000168	0.00444	CbGeAlD
Venlafaxine—Discomfort—Hydroxyurea—brain cancer	0.000167	0.00111	CcSEcCtD
Venlafaxine—Neutropenia—Etoposide—brain cancer	0.000166	0.0011	CcSEcCtD
Venlafaxine—Urticaria—Procarbazine—brain cancer	0.000166	0.0011	CcSEcCtD
Venlafaxine—Tinnitus—Temozolomide—brain cancer	0.000166	0.0011	CcSEcCtD
Venlafaxine—Abdominal pain—Procarbazine—brain cancer	0.000165	0.0011	CcSEcCtD
Venlafaxine—Body temperature increased—Procarbazine—brain cancer	0.000165	0.0011	CcSEcCtD
Venlafaxine—Cardiac disorder—Temozolomide—brain cancer	0.000165	0.00109	CcSEcCtD
Venlafaxine—Flushing—Temozolomide—brain cancer	0.000165	0.00109	CcSEcCtD
Venlafaxine—Arrhythmia—Carmustine—brain cancer	0.000164	0.00109	CcSEcCtD
Venlafaxine—Alopecia—Carmustine—brain cancer	0.000163	0.00108	CcSEcCtD
Venlafaxine—Oedema—Hydroxyurea—brain cancer	0.000162	0.00107	CcSEcCtD
Venlafaxine—Infection—Hydroxyurea—brain cancer	0.000161	0.00107	CcSEcCtD
Venlafaxine—Erythema—Carmustine—brain cancer	0.00016	0.00106	CcSEcCtD
Venlafaxine—Chills—Temozolomide—brain cancer	0.00016	0.00106	CcSEcCtD
Venlafaxine—Pneumonia—Etoposide—brain cancer	0.00016	0.00106	CcSEcCtD
Venlafaxine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000159	0.00638	CbGpPWpGaD
Venlafaxine—Thrombocytopenia—Hydroxyurea—brain cancer	0.000158	0.00105	CcSEcCtD
Venlafaxine—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000157	0.00104	CcSEcCtD
Venlafaxine—Alopecia—Temozolomide—brain cancer	0.000157	0.00104	CcSEcCtD
Venlafaxine—Acute coronary syndrome—Etoposide—brain cancer	0.000156	0.00104	CcSEcCtD
Venlafaxine—Renal failure—Etoposide—brain cancer	0.000156	0.00103	CcSEcCtD
Venlafaxine—ABCB1—midbrain—brain cancer	0.000156	0.00413	CbGeAlD
Venlafaxine—Neuropathy peripheral—Etoposide—brain cancer	0.000155	0.00103	CcSEcCtD
Venlafaxine—Myocardial infarction—Etoposide—brain cancer	0.000155	0.00103	CcSEcCtD
Venlafaxine—Back pain—Carmustine—brain cancer	0.000155	0.00103	CcSEcCtD
Venlafaxine—Erythema—Temozolomide—brain cancer	0.000155	0.00103	CcSEcCtD
Venlafaxine—Stomatitis—Etoposide—brain cancer	0.000155	0.00102	CcSEcCtD
Venlafaxine—Jaundice—Etoposide—brain cancer	0.000155	0.00102	CcSEcCtD
Venlafaxine—Anorexia—Hydroxyurea—brain cancer	0.000154	0.00102	CcSEcCtD
Venlafaxine—Hypersensitivity—Procarbazine—brain cancer	0.000154	0.00102	CcSEcCtD
Venlafaxine—ABCB1—spinal cord—brain cancer	0.000152	0.00403	CbGeAlD
Venlafaxine—Dysgeusia—Temozolomide—brain cancer	0.000152	0.00101	CcSEcCtD
Venlafaxine—NPY1R—GPCR ligand binding—SHH—brain cancer	0.000151	0.00608	CbGpPWpGaD
Venlafaxine—Vision blurred—Carmustine—brain cancer	0.000151	0.001	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—PTCH2—brain cancer	0.000151	0.00606	CbGpPWpGaD
Venlafaxine—Tremor—Carmustine—brain cancer	0.00015	0.000995	CcSEcCtD
Venlafaxine—Asthenia—Procarbazine—brain cancer	0.00015	0.000994	CcSEcCtD
Venlafaxine—Back pain—Temozolomide—brain cancer	0.00015	0.000993	CcSEcCtD
Venlafaxine—Anaemia—Carmustine—brain cancer	0.000148	0.000982	CcSEcCtD
Venlafaxine—Agranulocytosis—Etoposide—brain cancer	0.000148	0.000981	CcSEcCtD
Venlafaxine—Pruritus—Procarbazine—brain cancer	0.000148	0.00098	CcSEcCtD
Venlafaxine—Agitation—Carmustine—brain cancer	0.000147	0.000976	CcSEcCtD
Venlafaxine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000146	0.00587	CbGpPWpGaD
Venlafaxine—Vision blurred—Temozolomide—brain cancer	0.000146	0.000967	CcSEcCtD
Venlafaxine—Tremor—Temozolomide—brain cancer	0.000145	0.000962	CcSEcCtD
Venlafaxine—Dyspnoea—Hydroxyurea—brain cancer	0.000144	0.000956	CcSEcCtD
Venlafaxine—Somnolence—Hydroxyurea—brain cancer	0.000144	0.000953	CcSEcCtD
Venlafaxine—Ill-defined disorder—Temozolomide—brain cancer	0.000144	0.000952	CcSEcCtD
Venlafaxine—Leukopenia—Carmustine—brain cancer	0.000143	0.000951	CcSEcCtD
Venlafaxine—NPY1R—GPCR ligand binding—SMO—brain cancer	0.000143	0.00576	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—PTCH1—brain cancer	0.000143	0.00576	CbGpPWpGaD
Venlafaxine—Anaemia—Temozolomide—brain cancer	0.000143	0.000949	CcSEcCtD
Venlafaxine—Diarrhoea—Procarbazine—brain cancer	0.000143	0.000948	CcSEcCtD
Venlafaxine—Dyspepsia—Hydroxyurea—brain cancer	0.000142	0.000944	CcSEcCtD
Venlafaxine—Agitation—Temozolomide—brain cancer	0.000142	0.000943	CcSEcCtD
Venlafaxine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.000142	0.00571	CbGpPWpGaD
Venlafaxine—Hypoaesthesia—Etoposide—brain cancer	0.000142	0.000939	CcSEcCtD
Venlafaxine—Angioedema—Temozolomide—brain cancer	0.000142	0.000938	CcSEcCtD
Venlafaxine—Decreased appetite—Hydroxyurea—brain cancer	0.000141	0.000932	CcSEcCtD
Venlafaxine—Malaise—Temozolomide—brain cancer	0.00014	0.000926	CcSEcCtD
Venlafaxine—Fatigue—Hydroxyurea—brain cancer	0.00014	0.000924	CcSEcCtD
Venlafaxine—Vertigo—Temozolomide—brain cancer	0.000139	0.000922	CcSEcCtD
Venlafaxine—Convulsion—Carmustine—brain cancer	0.000139	0.00092	CcSEcCtD
Venlafaxine—Leukopenia—Temozolomide—brain cancer	0.000139	0.000919	CcSEcCtD
Venlafaxine—Hypertension—Carmustine—brain cancer	0.000138	0.000917	CcSEcCtD
Venlafaxine—Pain—Hydroxyurea—brain cancer	0.000138	0.000917	CcSEcCtD
Venlafaxine—Constipation—Hydroxyurea—brain cancer	0.000138	0.000917	CcSEcCtD
Venlafaxine—Dizziness—Procarbazine—brain cancer	0.000138	0.000916	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—OR14C36—brain cancer	0.000138	0.00555	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—OR4C12—brain cancer	0.000138	0.00555	CbGpPWpGaD
Venlafaxine—Palpitations—Temozolomide—brain cancer	0.000137	0.000907	CcSEcCtD
Venlafaxine—ABCB1—endocrine gland—brain cancer	0.000137	0.00363	CbGeAlD
Venlafaxine—Myalgia—Carmustine—brain cancer	0.000136	0.000904	CcSEcCtD
Venlafaxine—Chest pain—Carmustine—brain cancer	0.000136	0.000904	CcSEcCtD
Venlafaxine—CYP2D6—brain—brain cancer	0.000136	0.00361	CbGeAlD
Venlafaxine—Anxiety—Carmustine—brain cancer	0.000136	0.000901	CcSEcCtD
Venlafaxine—Cough—Temozolomide—brain cancer	0.000135	0.000896	CcSEcCtD
Venlafaxine—ABCB1—head—brain cancer	0.000135	0.00358	CbGeAlD
Venlafaxine—Erythema multiforme—Etoposide—brain cancer	0.000135	0.000892	CcSEcCtD
Venlafaxine—Convulsion—Temozolomide—brain cancer	0.000134	0.000889	CcSEcCtD
Venlafaxine—Hypertension—Temozolomide—brain cancer	0.000134	0.000886	CcSEcCtD
Venlafaxine—Feeling abnormal—Hydroxyurea—brain cancer	0.000133	0.000884	CcSEcCtD
Venlafaxine—Vomiting—Procarbazine—brain cancer	0.000133	0.000881	CcSEcCtD
Venlafaxine—Flushing—Etoposide—brain cancer	0.000132	0.000876	CcSEcCtD
Venlafaxine—Cardiac disorder—Etoposide—brain cancer	0.000132	0.000876	CcSEcCtD
Venlafaxine—Confusional state—Carmustine—brain cancer	0.000132	0.000874	CcSEcCtD
Venlafaxine—Myalgia—Temozolomide—brain cancer	0.000132	0.000874	CcSEcCtD
Venlafaxine—Arthralgia—Temozolomide—brain cancer	0.000132	0.000874	CcSEcCtD
Venlafaxine—Rash—Procarbazine—brain cancer	0.000132	0.000874	CcSEcCtD
Venlafaxine—Dermatitis—Procarbazine—brain cancer	0.000132	0.000873	CcSEcCtD
Venlafaxine—Anxiety—Temozolomide—brain cancer	0.000131	0.000871	CcSEcCtD
Venlafaxine—Headache—Procarbazine—brain cancer	0.000131	0.000868	CcSEcCtD
Venlafaxine—Oedema—Carmustine—brain cancer	0.000131	0.000867	CcSEcCtD
Venlafaxine—Discomfort—Temozolomide—brain cancer	0.00013	0.000863	CcSEcCtD
Venlafaxine—NPY1R—GPCR downstream signaling—ABR—brain cancer	0.00013	0.00523	CbGpPWpGaD
Venlafaxine—Infection—Carmustine—brain cancer	0.00013	0.000861	CcSEcCtD
Venlafaxine—Dry mouth—Temozolomide—brain cancer	0.000129	0.000855	CcSEcCtD
Venlafaxine—Thrombocytopenia—Carmustine—brain cancer	0.000128	0.000849	CcSEcCtD
Venlafaxine—Body temperature increased—Hydroxyurea—brain cancer	0.000128	0.000848	CcSEcCtD
Venlafaxine—Chills—Etoposide—brain cancer	0.000128	0.000847	CcSEcCtD
Venlafaxine—Tachycardia—Carmustine—brain cancer	0.000128	0.000846	CcSEcCtD
Venlafaxine—Confusional state—Temozolomide—brain cancer	0.000127	0.000845	CcSEcCtD
Venlafaxine—Oedema—Temozolomide—brain cancer	0.000126	0.000838	CcSEcCtD
Venlafaxine—Anaphylactic shock—Temozolomide—brain cancer	0.000126	0.000838	CcSEcCtD
Venlafaxine—Alopecia—Etoposide—brain cancer	0.000126	0.000834	CcSEcCtD
Venlafaxine—Infection—Temozolomide—brain cancer	0.000126	0.000832	CcSEcCtD
Venlafaxine—Anorexia—Carmustine—brain cancer	0.000125	0.000826	CcSEcCtD
Venlafaxine—Nausea—Procarbazine—brain cancer	0.000124	0.000823	CcSEcCtD
Venlafaxine—Thrombocytopenia—Temozolomide—brain cancer	0.000124	0.00082	CcSEcCtD
Venlafaxine—ABCB1—central nervous system—brain cancer	0.000123	0.00327	CbGeAlD
Venlafaxine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000123	0.00495	CbGpPWpGaD
Venlafaxine—Hypotension—Carmustine—brain cancer	0.000122	0.00081	CcSEcCtD
Venlafaxine—Hyperhidrosis—Temozolomide—brain cancer	0.000122	0.00081	CcSEcCtD
Venlafaxine—Dysgeusia—Etoposide—brain cancer	0.000121	0.000804	CcSEcCtD
Venlafaxine—Anorexia—Temozolomide—brain cancer	0.000121	0.000799	CcSEcCtD
Venlafaxine—ABCB1—cerebellum—brain cancer	0.000121	0.0032	CbGeAlD
Venlafaxine—Back pain—Etoposide—brain cancer	0.00012	0.000794	CcSEcCtD
Venlafaxine—Hypersensitivity—Hydroxyurea—brain cancer	0.000119	0.00079	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Carmustine—brain cancer	0.000119	0.00079	CcSEcCtD
Venlafaxine—Muscle spasms—Etoposide—brain cancer	0.000119	0.00079	CcSEcCtD
Venlafaxine—Insomnia—Carmustine—brain cancer	0.000118	0.000784	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—ABR—brain cancer	0.000118	0.00475	CbGpPWpGaD
Venlafaxine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000118	0.00473	CbGpPWpGaD
Venlafaxine—Paraesthesia—Carmustine—brain cancer	0.000117	0.000778	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—DTX2—brain cancer	0.000117	0.00472	CbGpPWpGaD
Venlafaxine—Dyspnoea—Carmustine—brain cancer	0.000117	0.000773	CcSEcCtD
Venlafaxine—Somnolence—Carmustine—brain cancer	0.000116	0.000771	CcSEcCtD
Venlafaxine—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000116	0.00467	CbGpPWpGaD
Venlafaxine—Asthenia—Hydroxyurea—brain cancer	0.000116	0.000769	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000115	0.000763	CcSEcCtD
Venlafaxine—Ill-defined disorder—Etoposide—brain cancer	0.000115	0.000762	CcSEcCtD
Venlafaxine—Anaemia—Etoposide—brain cancer	0.000115	0.000759	CcSEcCtD
Venlafaxine—Insomnia—Temozolomide—brain cancer	0.000114	0.000758	CcSEcCtD
Venlafaxine—Decreased appetite—Carmustine—brain cancer	0.000114	0.000754	CcSEcCtD
Venlafaxine—Paraesthesia—Temozolomide—brain cancer	0.000114	0.000752	CcSEcCtD
Venlafaxine—Dyspnoea—Temozolomide—brain cancer	0.000113	0.000747	CcSEcCtD
Venlafaxine—Somnolence—Temozolomide—brain cancer	0.000112	0.000745	CcSEcCtD
Venlafaxine—Constipation—Carmustine—brain cancer	0.000112	0.000741	CcSEcCtD
Venlafaxine—Pain—Carmustine—brain cancer	0.000112	0.000741	CcSEcCtD
Venlafaxine—Malaise—Etoposide—brain cancer	0.000112	0.000741	CcSEcCtD
Venlafaxine—CYP2B6—Biological oxidations—CYP2C9—brain cancer	0.000112	0.00449	CbGpPWpGaD
Venlafaxine—Vertigo—Etoposide—brain cancer	0.000111	0.000738	CcSEcCtD
Venlafaxine—Dyspepsia—Temozolomide—brain cancer	0.000111	0.000737	CcSEcCtD
Venlafaxine—Leukopenia—Etoposide—brain cancer	0.000111	0.000735	CcSEcCtD
Venlafaxine—Diarrhoea—Hydroxyurea—brain cancer	0.000111	0.000734	CcSEcCtD
Venlafaxine—CYP2B6—Metapathway biotransformation—CYP2C9—brain cancer	0.00011	0.00442	CbGpPWpGaD
Venlafaxine—Decreased appetite—Temozolomide—brain cancer	0.00011	0.000728	CcSEcCtD
Venlafaxine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.00011	0.00441	CbGpPWpGaD
Venlafaxine—Fatigue—Temozolomide—brain cancer	0.000109	0.000722	CcSEcCtD
Venlafaxine—Loss of consciousness—Etoposide—brain cancer	0.000109	0.000722	CcSEcCtD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000109	0.00437	CbGpPWpGaD
Venlafaxine—Cough—Etoposide—brain cancer	0.000108	0.000717	CcSEcCtD
Venlafaxine—Pain—Temozolomide—brain cancer	0.000108	0.000716	CcSEcCtD
Venlafaxine—Constipation—Temozolomide—brain cancer	0.000108	0.000716	CcSEcCtD
Venlafaxine—Feeling abnormal—Carmustine—brain cancer	0.000108	0.000714	CcSEcCtD
Venlafaxine—Convulsion—Etoposide—brain cancer	0.000107	0.000712	CcSEcCtD
Venlafaxine—Hypertension—Etoposide—brain cancer	0.000107	0.000709	CcSEcCtD
Venlafaxine—Dizziness—Hydroxyurea—brain cancer	0.000107	0.000709	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Carmustine—brain cancer	0.000107	0.000709	CcSEcCtD
Venlafaxine—Chest pain—Etoposide—brain cancer	0.000106	0.000699	CcSEcCtD
Venlafaxine—SLC6A3—Dopaminergic Neurogenesis—STAT3—brain cancer	0.000105	0.00423	CbGpPWpGaD
Venlafaxine—Discomfort—Etoposide—brain cancer	0.000104	0.000691	CcSEcCtD
Venlafaxine—Feeling abnormal—Temozolomide—brain cancer	0.000104	0.00069	CcSEcCtD
Venlafaxine—Abdominal pain—Carmustine—brain cancer	0.000103	0.000685	CcSEcCtD
Venlafaxine—Body temperature increased—Carmustine—brain cancer	0.000103	0.000685	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Temozolomide—brain cancer	0.000103	0.000685	CcSEcCtD
Venlafaxine—Vomiting—Hydroxyurea—brain cancer	0.000103	0.000682	CcSEcCtD
Venlafaxine—Rash—Hydroxyurea—brain cancer	0.000102	0.000676	CcSEcCtD
Venlafaxine—Confusional state—Etoposide—brain cancer	0.000102	0.000676	CcSEcCtD
Venlafaxine—Dermatitis—Hydroxyurea—brain cancer	0.000102	0.000675	CcSEcCtD
Venlafaxine—Headache—Hydroxyurea—brain cancer	0.000101	0.000672	CcSEcCtD
Venlafaxine—Anaphylactic shock—Etoposide—brain cancer	0.000101	0.00067	CcSEcCtD
Venlafaxine—Infection—Etoposide—brain cancer	0.000101	0.000666	CcSEcCtD
Venlafaxine—Urticaria—Temozolomide—brain cancer	0.0001	0.000665	CcSEcCtD
Venlafaxine—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.0001	0.00402	CbGpPWpGaD
Venlafaxine—Abdominal pain—Temozolomide—brain cancer	9.99e-05	0.000662	CcSEcCtD
Venlafaxine—Body temperature increased—Temozolomide—brain cancer	9.99e-05	0.000662	CcSEcCtD
Venlafaxine—Thrombocytopenia—Etoposide—brain cancer	9.9e-05	0.000656	CcSEcCtD
Venlafaxine—Tachycardia—Etoposide—brain cancer	9.87e-05	0.000654	CcSEcCtD
Venlafaxine—ABCB1—brain—brain cancer	9.79e-05	0.0026	CbGeAlD
Venlafaxine—Hyperhidrosis—Etoposide—brain cancer	9.78e-05	0.000648	CcSEcCtD
Venlafaxine—Anorexia—Etoposide—brain cancer	9.64e-05	0.000639	CcSEcCtD
Venlafaxine—Hypersensitivity—Carmustine—brain cancer	9.64e-05	0.000639	CcSEcCtD
Venlafaxine—Nausea—Hydroxyurea—brain cancer	9.61e-05	0.000637	CcSEcCtD
Venlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	9.55e-05	0.00384	CbGpPWpGaD
Venlafaxine—Hypotension—Etoposide—brain cancer	9.45e-05	0.000626	CcSEcCtD
Venlafaxine—Asthenia—Carmustine—brain cancer	9.39e-05	0.000622	CcSEcCtD
Venlafaxine—Hypersensitivity—Temozolomide—brain cancer	9.31e-05	0.000617	CcSEcCtD
Venlafaxine—Paraesthesia—Etoposide—brain cancer	9.08e-05	0.000602	CcSEcCtD
Venlafaxine—Asthenia—Temozolomide—brain cancer	9.07e-05	0.000601	CcSEcCtD
Venlafaxine—Dyspnoea—Etoposide—brain cancer	9.02e-05	0.000598	CcSEcCtD
Venlafaxine—Somnolence—Etoposide—brain cancer	8.99e-05	0.000596	CcSEcCtD
Venlafaxine—Diarrhoea—Carmustine—brain cancer	8.95e-05	0.000593	CcSEcCtD
Venlafaxine—Pruritus—Temozolomide—brain cancer	8.94e-05	0.000593	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—PTCH2—brain cancer	8.9e-05	0.00358	CbGpPWpGaD
Venlafaxine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	8.87e-05	0.00357	CbGpPWpGaD
Venlafaxine—ABCG2—HIF-2-alpha transcription factor network—VEGFA—brain cancer	8.83e-05	0.00355	CbGpPWpGaD
Venlafaxine—Decreased appetite—Etoposide—brain cancer	8.79e-05	0.000583	CcSEcCtD
Venlafaxine—Fatigue—Etoposide—brain cancer	8.72e-05	0.000578	CcSEcCtD
Venlafaxine—Dizziness—Carmustine—brain cancer	8.65e-05	0.000573	CcSEcCtD
Venlafaxine—Constipation—Etoposide—brain cancer	8.65e-05	0.000573	CcSEcCtD
Venlafaxine—Pain—Etoposide—brain cancer	8.65e-05	0.000573	CcSEcCtD
Venlafaxine—Diarrhoea—Temozolomide—brain cancer	8.65e-05	0.000573	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—HES5—brain cancer	8.62e-05	0.00346	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—HES1—brain cancer	8.44e-05	0.00339	CbGpPWpGaD
Venlafaxine—CYP2C19—Biological oxidations—CYP2C9—brain cancer	8.43e-05	0.00339	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—STRADA—brain cancer	8.37e-05	0.00336	CbGpPWpGaD
Venlafaxine—Dizziness—Temozolomide—brain cancer	8.36e-05	0.000554	CcSEcCtD
Venlafaxine—Feeling abnormal—Etoposide—brain cancer	8.34e-05	0.000552	CcSEcCtD
Venlafaxine—Vomiting—Carmustine—brain cancer	8.32e-05	0.000551	CcSEcCtD
Venlafaxine—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	8.32e-05	0.00334	CbGpPWpGaD
Venlafaxine—Gastrointestinal pain—Etoposide—brain cancer	8.27e-05	0.000548	CcSEcCtD
Venlafaxine—Rash—Carmustine—brain cancer	8.25e-05	0.000547	CcSEcCtD
Venlafaxine—Dermatitis—Carmustine—brain cancer	8.24e-05	0.000546	CcSEcCtD
Venlafaxine—NPY1R—GPCR downstream signaling—TRPC6—brain cancer	8.24e-05	0.00331	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—S100A10—brain cancer	8.24e-05	0.00331	CbGpPWpGaD
Venlafaxine—Headache—Carmustine—brain cancer	8.2e-05	0.000543	CcSEcCtD
Venlafaxine—Vomiting—Temozolomide—brain cancer	8.04e-05	0.000533	CcSEcCtD
Venlafaxine—Urticaria—Etoposide—brain cancer	8.04e-05	0.000533	CcSEcCtD
Venlafaxine—Body temperature increased—Etoposide—brain cancer	8e-05	0.00053	CcSEcCtD
Venlafaxine—Abdominal pain—Etoposide—brain cancer	8e-05	0.00053	CcSEcCtD
Venlafaxine—Rash—Temozolomide—brain cancer	7.97e-05	0.000528	CcSEcCtD
Venlafaxine—Dermatitis—Temozolomide—brain cancer	7.96e-05	0.000528	CcSEcCtD
Venlafaxine—Headache—Temozolomide—brain cancer	7.92e-05	0.000525	CcSEcCtD
Venlafaxine—Nausea—Carmustine—brain cancer	7.77e-05	0.000515	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—SHH—brain cancer	7.76e-05	0.00312	CbGpPWpGaD
Venlafaxine—CYP2D6—Biological oxidations—CYP2C9—brain cancer	7.76e-05	0.00312	CbGpPWpGaD
Venlafaxine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	7.69e-05	0.00309	CbGpPWpGaD
Venlafaxine—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	7.65e-05	0.00308	CbGpPWpGaD
Venlafaxine—Nausea—Temozolomide—brain cancer	7.51e-05	0.000498	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—TRPC6—brain cancer	7.48e-05	0.00301	CbGpPWpGaD
Venlafaxine—Hypersensitivity—Etoposide—brain cancer	7.45e-05	0.000494	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—SMO—brain cancer	7.36e-05	0.00296	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—PTCH1—brain cancer	7.36e-05	0.00296	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—S100A10—brain cancer	7.3e-05	0.00293	CbGpPWpGaD
Venlafaxine—Asthenia—Etoposide—brain cancer	7.26e-05	0.000481	CcSEcCtD
Venlafaxine—Pruritus—Etoposide—brain cancer	7.16e-05	0.000474	CcSEcCtD
Venlafaxine—SLC6A4—Circadian rythm related genes—SIRT1—brain cancer	7.15e-05	0.00287	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—ABR—brain cancer	6.98e-05	0.00281	CbGpPWpGaD
Venlafaxine—Diarrhoea—Etoposide—brain cancer	6.92e-05	0.000459	CcSEcCtD
Venlafaxine—ABCG2—Fluoropyrimidine Activity—TP53—brain cancer	6.83e-05	0.00275	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—GLI2—brain cancer	6.74e-05	0.00271	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—S100A10—brain cancer	6.71e-05	0.0027	CbGpPWpGaD
Venlafaxine—Dizziness—Etoposide—brain cancer	6.69e-05	0.000443	CcSEcCtD
Venlafaxine—Vomiting—Etoposide—brain cancer	6.43e-05	0.000426	CcSEcCtD
Venlafaxine—Rash—Etoposide—brain cancer	6.38e-05	0.000423	CcSEcCtD
Venlafaxine—Dermatitis—Etoposide—brain cancer	6.37e-05	0.000422	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—GLI1—brain cancer	6.34e-05	0.00255	CbGpPWpGaD
Venlafaxine—Headache—Etoposide—brain cancer	6.34e-05	0.00042	CcSEcCtD
Venlafaxine—NPY1R—GPCR downstream signaling—VAV1—brain cancer	6.17e-05	0.00248	CbGpPWpGaD
Venlafaxine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	6.06e-05	0.00244	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—SUFU—brain cancer	6.01e-05	0.00242	CbGpPWpGaD
Venlafaxine—Nausea—Etoposide—brain cancer	6.01e-05	0.000398	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—GFAP—brain cancer	5.8e-05	0.00233	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—VAV1—brain cancer	5.61e-05	0.00225	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—HEY1—brain cancer	5.5e-05	0.00221	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—CDK4—brain cancer	5.4e-05	0.00217	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—DLL1—brain cancer	5.39e-05	0.00217	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—PDGFRA—brain cancer	5.24e-05	0.00211	CbGpPWpGaD
Venlafaxine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—brain cancer	5.19e-05	0.00209	CbGpPWpGaD
Venlafaxine—CYP3A4—Biological oxidations—CYP2C9—brain cancer	5.07e-05	0.00204	CbGpPWpGaD
Venlafaxine—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	5e-05	0.00201	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—SHH—brain cancer	4.58e-05	0.00184	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—TRPC6—brain cancer	4.42e-05	0.00178	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	4.37e-05	0.00176	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—PTCH1—brain cancer	4.35e-05	0.00175	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—SMO—brain cancer	4.35e-05	0.00175	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—CTNNB1—brain cancer	4.23e-05	0.0017	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	4.15e-05	0.00167	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—PIK3CG—brain cancer	3.92e-05	0.00158	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—TRPC6—brain cancer	3.8e-05	0.00153	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—brain cancer	3.73e-05	0.0015	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	3.63e-05	0.00146	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—PIK3CG—brain cancer	3.56e-05	0.00143	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	3.5e-05	0.00141	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—NOTCH2—brain cancer	3.47e-05	0.0014	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—TRPC6—brain cancer	3.37e-05	0.00135	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—VAV1—brain cancer	3.31e-05	0.00133	CbGpPWpGaD
Venlafaxine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	3.28e-05	0.00132	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.24e-05	0.0013	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—TRPC6—brain cancer	3.1e-05	0.00125	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	2.87e-05	0.00116	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—IL2—brain cancer	2.86e-05	0.00115	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—HES1—brain cancer	2.85e-05	0.00114	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	2.82e-05	0.00113	CbGpPWpGaD
Venlafaxine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	2.81e-05	0.00113	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	2.78e-05	0.00112	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—IL2—brain cancer	2.76e-05	0.00111	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—PDGFRA—brain cancer	2.71e-05	0.00109	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—SPP1—brain cancer	2.63e-05	0.00106	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—CYP2C9—brain cancer	2.6e-05	0.00105	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	2.59e-05	0.00104	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—IL2—brain cancer	2.51e-05	0.00101	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	2.47e-05	0.000991	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—VEGFA—brain cancer	2.43e-05	0.000978	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—IRS2—brain cancer	2.38e-05	0.000957	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.37e-05	0.000952	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—TP53—brain cancer	2.3e-05	0.000924	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—BSG—brain cancer	2.21e-05	0.00089	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.16e-05	0.000868	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	2.13e-05	0.000857	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—APC—brain cancer	2.1e-05	0.000845	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—PIK3CG—brain cancer	2.1e-05	0.000845	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	2.01e-05	0.000807	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—EGFR—brain cancer	1.92e-05	0.00077	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—CYP2C9—brain cancer	1.91e-05	0.000767	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—IDH1—brain cancer	1.9e-05	0.000765	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.67e-05	0.000673	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—RELA—brain cancer	1.64e-05	0.000661	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—ERBB2—brain cancer	1.63e-05	0.000656	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—BSG—brain cancer	1.62e-05	0.000652	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	1.56e-05	0.000626	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—ENO2—brain cancer	1.5e-05	0.000605	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—IL2—brain cancer	1.48e-05	0.000595	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CCND1—brain cancer	1.44e-05	0.00058	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CYP2C9—brain cancer	1.44e-05	0.00058	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CTNNB1—brain cancer	1.43e-05	0.000574	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CYP2C9—brain cancer	1.41e-05	0.000566	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—IDH1—brain cancer	1.4e-05	0.000561	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.38e-05	0.000553	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.36e-05	0.000548	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CYP2C9—brain cancer	1.33e-05	0.000533	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—VEGFA—brain cancer	1.26e-05	0.000506	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—STAT3—brain cancer	1.25e-05	0.000501	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—BSG—brain cancer	1.23e-05	0.000493	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.2e-05	0.000482	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—BSG—brain cancer	1.2e-05	0.000481	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—MYC—brain cancer	1.16e-05	0.000465	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—EGFR—brain cancer	1.13e-05	0.000455	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—BSG—brain cancer	1.13e-05	0.000453	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—BSG—brain cancer	1.12e-05	0.000449	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.1e-05	0.000444	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—ENO2—brain cancer	1.1e-05	0.000443	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.08e-05	0.000434	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—IDH1—brain cancer	1.05e-05	0.000424	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—IDH1—brain cancer	1.03e-05	0.000414	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—IDH1—brain cancer	9.7e-06	0.00039	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—IDH1—brain cancer	9.61e-06	0.000386	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—TP53—brain cancer	9.5e-06	0.000382	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	9.07e-06	0.000365	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CYP2C9—brain cancer	8.67e-06	0.000349	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.59e-06	0.000345	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—ENO2—brain cancer	8.34e-06	0.000335	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—ENO2—brain cancer	8.14e-06	0.000327	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.83e-06	0.000315	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—ENO2—brain cancer	7.67e-06	0.000308	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—ENO2—brain cancer	7.6e-06	0.000306	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—BSG—brain cancer	7.37e-06	0.000296	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PIK3CG—brain cancer	6.9e-06	0.000277	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—IDH1—brain cancer	6.34e-06	0.000255	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PIK3CG—brain cancer	5.06e-06	0.000203	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—ENO2—brain cancer	5.01e-06	0.000201	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PIK3CG—brain cancer	3.82e-06	0.000154	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PIK3CG—brain cancer	3.73e-06	0.00015	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PIK3CG—brain cancer	3.52e-06	0.000141	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PIK3CG—brain cancer	3.49e-06	0.00014	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PIK3CG—brain cancer	2.3e-06	9.24e-05	CbGpPWpGaD
